Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $27 to $24.
JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $26 to $24.
UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $28 to $22.
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $31 to $28.
Stifel analyst Nathan Janes maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $29 to $24.
Adient Plc (NYSE: ADNT) shares down after reporting mixed Q4 results. Adjusted earnings at 52 cents per share, missing estimate...
Consolidated sales of ~$14.4B Sales expected to be ~$14.4B, driven by lower y-o-y production volumesAdj.-EBITDA is expected to ...
